Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
234 hedge funds and large institutions have $3.05B invested in Cantel Medical Corporation in 2021 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 63 increasing their positions, 86 reducing their positions, and 51 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
14% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 51
2% more funds holding
Funds holding: 229 → 234 (+5)
3% less capital invested
Capital invested by funds: $3.16B → $3.05B (-$108M)
27% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 86
76% less call options, than puts
Call options by funds: $741K | Put options by funds: $3.03M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$74.8M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$54.7M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$45.7M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$45.1M |
| 5 |
WIC
Water Island Capital
New York
|
+$35.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$256M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$115M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$57.2M |
| 4 |
LGP
Leonard Green & Partners
Los Angeles,
California
|
-$46.9M |
| 5 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$40.2M |
CMD Hedge Fund Activity: Q1 2021 in Review
234 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q1 2021, worth a combined $3.05B — down 3.4% from $3.16B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new CMD positions and 51 closed out — a net gain of 7 holders — while 63 added to existing stakes and 86 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $74.8M. The largest seller was Fred Alger Management, cutting an estimated $256M.
- 234 institutional investors held Cantel Medical Corporation (CMD) as of Q1 2021, up from 229 in Q4 2020.
- Funds reported $3.05B of Cantel Medical Corporation stock for Q1 2021, down 3.4% quarter-over-quarter.
- 58 funds opened new Cantel Medical Corporation positions in Q1 2021 and 51 closed out, a net change of +7 holders.
- The largest Cantel Medical Corporation buyer in Q1 2021 was Citadel Advisors, an estimated $74.8M added.
- The largest Cantel Medical Corporation seller in Q1 2021 was Fred Alger Management, an estimated $256M sold.
Based on aggregated 13F filings for Q1 2021.